A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
NCT07050394
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer Metastatic
Colorectal Cancer Recurrent
Colorectal Cancer Stage IV
Interventions
DRUG:
CD-GA-102
Sponsor
Shanghai Changzheng Hospital